Bio-Rad Laboratories BIO
NYSE BIO
$366.15 -4.35 (-1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Bio-Rad Laboratories (BIO) Gross Profit (2009 - 2026)

Updated

Bio-Rad Laboratories' Gross Profit came in at $328.6 million for Q3 2026, down 4.3% from $343.4 million a year earlier and down 5.0% from the prior quarter.

Analysis

Bio-Rad Laboratories (BIO) Gross Profit (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Bio-Rad Laboratories reported Gross Profit of $1.33 billion, down 0.6% year-over-year; for FY2025, it came in at $1.34 billion, down 2.8% from FY2024.

  • Gross Profit has declined in each of the last four years, with a five-year compound annual growth rate of -1.4% (FY2020 to FY2025).
  • Going back by year, Gross Profit was $1.38 billion in FY2024 (-3.4%), $1.43 billion in FY2023 (-9.0%), $1.57 billion in FY2022 (-4.3%) and $1.64 billion in FY2021 (+13.9%).
  • The five-year range for quarterly Gross Profit is $306 million (Q1 2025) to $402.6 million (Q1 2022).
  • Year-over-year, Gross Profit increased in three of the last eight quarters, with an average decline of 2.6%.
  • The fastest year-over-year change in Gross Profit over five years came in Q3 2024 (growth of 6.0%), and the weakest in Q3 2022 (a decline of 14.6%).
  • Business Quant data shows BIO's Gross Profit at $345.8 million (Q2 2026), $309.4 million (Q1 2026) and $345.2 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Bio-Rad Laboratories Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=BIO&period=max&api_key=YOUR_API_KEY